Cloud-Based eClinical Platforms and Multicenter Trial Efficiency Driving the China Eclinical Solution Market
Modernizing clinical trial infrastructure, adopting unified eClinical software platforms, and scaling multicenter biopharmaceutical R&D are driving rapid expansion across the China Eclinical Solution Market. Regulatory reforms initiated by the National Medical Products Administration (NMPA) align Chinese clinical trial standards with International Council for Harmonisation (ICH) guidelines....
0 Comentários 0 Compartilhamentos 173 Visualizações 0 Anterior